Loading clinical trials...
Loading clinical trials...
Evaluation of the Effectiveness of Fecal Microbiota Transplantation in the Treatment of Patients With Severe Low Anterior Resection Syndrome (LARS)
Conditions
Interventions
fecal microbiota transplantation
Formulated probiotic supplements
Start Date
January 1, 2025
Primary Completion Date
June 30, 2026
Completion Date
December 31, 2026
Last Updated
June 26, 2024
NCT03325855
NCT05943444
NCT06569966
NCT05790356
NCT06205862
NCT01790061
Lead Sponsor
Peking University People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions